Phase II randomized, open-label study of cetuximab (Cet) and bevacizumab (Bev) in combination with paclitaxel (P) and carboplatin (C) in patients with stageIII/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Bonomi, P. D. [1 ]
Mace, J. [1 ]
Mandanas, R. D. [1 ]
Min, M. [1 ]
Zhang, Y. [1 ]
Rowinsky, E. [1 ]
Youssoufian, H. [1 ]
机构：
[1] Rush Univ, Ctr Med, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Paclitaxel and Carboplatin in combination with Gemcitabine (PCG): A phase I-II trial in non-small cell lung cancer (NSCLC)
    Favaretto, A
    Paccagnella, A
    Tumolo, S
    Barbieri, F
    Ceresoli, G
    Gulisano, M
    Oniga, F
    Bearz, A
    Fiorentino, MV
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [42] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Ukena, D
    Berg, M
    Leutz, M
    Zell, L
    Schlimmer, P
    Sybrecht, GW
    LUNG CANCER, 1998, 19 (01) : 31 - 36
  • [43] PGG β-GLUCAN WITH CARBOPLATIN, PACLITAXEL AND CETUXIMAB FOR CHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Schneller, F.
    Thomas, M.
    Sadjadian, P.
    Kollmeier, J.
    Bose, N.
    Antonysamy, M.
    Patchen, M.
    Lowe, J.
    Huhn, R. D.
    Mattson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S40 - S41
  • [44] A phase Ib study to evaluate the PI3-kinase inhibitor GDC-0941 with paclitaxel (P) and carboplatin (C), with and without bevacizumab (BEV), in patients with advanced non-small cell lung cancer (NSCLC).
    Besse, B.
    Soria, J.
    Gomez-Roca, C.
    Ware, J. A.
    Adjei, A. A.
    Dy, G. K.
    Shankar, G.
    Brachmann, R. K.
    Groen, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer
    Thienelt, CD
    Bunn, PA
    Hanna, N
    Rosenberg, A
    Needle, MN
    Long, ME
    Gustafson, DL
    Kelly, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8786 - 8793
  • [46] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [47] Phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in selected patients (pts) with advanced non-small cell lung cancer (NSCLC) (IPASS): Evaluation of recruits in Japan
    Ohe, Y.
    Ichinose, Y.
    Nishiwaki, Y.
    Yamamoto, N.
    Negoro, S.
    Duffield, E.
    Jiang, H.
    Saijo, N.
    Mok, T.
    Fukuoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Results of OPN-017
    Borghaei, Hossein
    Langer, Corey J.
    Millenson, Michael
    Ruth, Karen J.
    Litwin, Samuel
    Tuttle, Holly
    Seldomridge, Judie Sylvester
    Rovito, Marc
    Mintzer, David
    Cohen, Roger
    Treat, Joseph
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (11) : 1286 - 1292
  • [49] Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer
    Okamoto, I
    Moriyama, E
    Fujii, S
    Kishi, H
    Nomura, M
    Goto, E
    Kiyofuji, C
    Imamura, F
    Mori, T
    Matsumoto, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (04) : 188 - 194
  • [50] Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer
    Bertino, Erin
    Villalona-Calero, Miguel A.
    Ross, Patrick
    Grever, Michael
    Otterson, Gregory A.
    ANNALS OF THORACIC SURGERY, 2011, 91 (02): : 640 - 640
12345